The company was identified as the first batch of continuing education base for skilled talents in Jinhua City
Release time:
2022-03-01
23 units such as Jianfeng Group were identified as the first batch of continuing education bases for skilled talents in Jinhua City. It is understood that the continuing education base for skilled personnel is mainly responsible for the continuing education and training of skilled personnel, and is responsible for organizing continuing education and teaching activities and daily management of related occupations (types of work). The list of units applying for continuing education bases shall be recommended by the human resources and social security bureaus of all counties (cities and districts) in Jinhua and the competent departments of various industries. The application units shall submit the application materials as required, and the human resources and social security bureaus of all counties (cities and districts) and the competent departments of various industries shall be submitted to the Municipal Bureau of human resources and social security for evaluation, filing and publication. The continuing education base for skilled talents that has passed the record is managed by the human resources and social security bureaus of each county (city, district) and the competent departments of various industries, and the Municipal Human Resources and Social Security Bureau conducts assessment and evaluation. Among them, the application conditions of continuing education base put forward specific requirements from the aspects of teaching staff, training management system, teaching places, facilities and equipment, management standards and so on.
Jianfeng Group has always attached great importance to staff training and continuing education, and has strong ability and experience in continuing education and training of skilled personnel, which basically meets the conditions for applying for a continuing education base for skilled personnel. Jianfeng Group has established an excellent team of internal trainers, with a relatively stable team of high-quality trainers to meet training needs, and the group company has also set up a training center, established a three-level training system, and has staff training and education management institutions and staff. There is a sound staff education and training management system, with clear work functions, which can standardize the management of trainees and training work; it has teaching places, facilities and equipment suitable for continuing education, which can not only provide a place for skilled personnel to carry out practical training, but also has a corporate university platform, which can carry out independent learning and training online; the internal management standard is a pilot unit for vocational skill level identification that has been reviewed and evaluated by Zhejiang Province and Jinhua City, It has undertaken general-purpose training in economics, management, macro situation, etc., as well as professional training in industry policy and technological development. Xiang Chongping, deputy general manager of
group company, said that the application for Jinhua skilled personnel continuing education base can be matched with the company's independent identification of vocational skills level to form a complete set of skilled personnel development system. Employees can complete continuing education in the company, which can not only provide convenience in time and place arrangement, but also be more in line with the actual work of employees, and be more effective in mastering talent knowledge and skills. After being identified as a continuing education base for skilled personnel, the company will also provide continuing education and training for relevant skilled personnel according to their needs, continuously improve the quality of continuing education and service level, and provide strong support for the high-quality development of Jinhua.
(Reporter
Ni Yingzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31